Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
605.00
+5.31 (0.89%)
Aug 11, 2026, 4:00 PM EDT - Market closed
Thermo Fisher Revenue
Thermo Fisher had revenue of $11.99B in the quarter ending June 27, 2026, with 10.49% growth. This brings the company's revenue in the last twelve months to $46.34B, up 7.23% year-over-year. In the year 2025, Thermo Fisher had annual revenue of $44.56B with 3.91% growth.
Revenue (ttm)
$46.34B
Revenue Growth
+7.23%
P/S Ratio
4.83
Revenue / Employee
$370,688
Employees
125,000
Market Cap
223.70B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.56B | 1.68B | 3.91% |
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | 25.54B | 1.18B | 4.86% |
| Dec 31, 2018 | 24.36B | 3.44B | 16.45% |
| Dec 31, 2017 | 20.92B | 2.64B | 14.47% |
| Dec 31, 2016 | 18.27B | 1.31B | 7.72% |
| Dec 31, 2015 | 16.97B | 75.40M | 0.45% |
| Dec 31, 2014 | 16.89B | 3.80B | 29.02% |
| Dec 31, 2013 | 13.09B | 580.40M | 4.64% |
| Dec 31, 2012 | 12.51B | 951.10M | 8.23% |
| Dec 31, 2011 | 11.56B | 1.17B | 11.22% |
| Dec 31, 2010 | 10.39B | 481.50M | 4.86% |
| Dec 31, 2009 | 9.91B | -586.40M | -5.59% |
| Dec 31, 2008 | 10.50B | 751.60M | 7.71% |
| Dec 31, 2007 | 9.75B | 5.95B | 157.05% |
| Dec 31, 2006 | 3.79B | 1.16B | 44.00% |
| Dec 31, 2005 | 2.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danaher | 25.11B |
| IQVIA Holdings | 16.98B |
| Labcorp Holdings | 14.35B |
| Quest Diagnostics | 11.56B |
| Agilent Technologies | 7.23B |
| Waters | 4.64B |
| IDEXX Laboratories | 4.55B |
| Illumina | 4.49B |
TMO News
- 2 days ago - Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost - Reuters
- 6 days ago - Thermo Fisher price target raised to $650 from $600 at Stifel - TheFly
- 15 days ago - Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026 - Business Wire
- 15 days ago - Thermo Fisher price target raised to $600 from $510 at Piper Sandler - TheFly
- 18 days ago - Thermo Fisher price target raised to $650 from $620 at Morgan Stanley - TheFly
- 18 days ago - Thermo Fisher price target raised to $580 from $490 at RBC Capital - TheFly
- 18 days ago - Thermo Fisher Scientific Launches Thermo Scientific™ InstaFlux™ to Help Food Microbiology Labs Simplify Workflows in Pathogen and Environmental Testing - Business Wire
- 19 days ago - Thermo Fisher price target raised to $650 from $625 at Barclays - TheFly